FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

2683511000001107: Voltarol 100mg suppositories (Novartis Pharmaceuticals UK Ltd) 10 suppository (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25778901000001112 Voltarol 100mg suppositories (Novartis Pharmaceuticals UK Ltd) 10 suppository (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
25779001000001119 Voltarol 100mg suppositories (Novartis Pharmaceuticals UK Ltd) 10 suppository en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Voltarol 100mg suppositories (Novartis Pharmaceuticals UK Ltd) 10 suppository Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Voltarol 100mg suppositories (Novartis Pharmaceuticals UK Ltd) 10 suppository Is a Diclofenac 100mg suppositories 10 suppository true Inferred relationship Existential restriction modifier
Voltarol 100mg suppositories (Novartis Pharmaceuticals UK Ltd) 10 suppository Is pack of Voltarol 100mg suppositories (Novartis Pharmaceuticals UK Ltd) false Inferred relationship Existential restriction modifier
Voltarol 100mg suppositories (Novartis Pharmaceuticals UK Ltd) 10 suppository Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Voltarol 100mg suppositories (Novartis Pharmaceuticals UK Ltd) 10 suppository Has active ingredient Diclofenac sodium false Inferred relationship Existential restriction modifier
Voltarol 100mg suppositories (Novartis Pharmaceuticals UK Ltd) 10 suppository Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Voltarol 100mg suppositories (Novartis Pharmaceuticals UK Ltd) 10 suppository Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Voltarol 100mg suppositories (Novartis Pharmaceuticals UK Ltd) 10 suppository Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Voltarol 100mg suppositories (Novartis Pharmaceuticals UK Ltd) 10 suppository VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Voltarol 100mg suppositories (Novartis Pharmaceuticals UK Ltd) 10 suppository VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Voltarol 100mg suppositories (Novartis Pharmaceuticals UK Ltd) 10 suppository Has manufactured dose form Suppository false Inferred relationship Existential restriction modifier
Voltarol 100mg suppositories (Novartis Pharmaceuticals UK Ltd) 10 suppository Has AMP Voltarol 100mg suppositories (Novartis Pharmaceuticals UK Ltd) true Inferred relationship Existential restriction modifier
Voltarol 100mg suppositories (Novartis Pharmaceuticals UK Ltd) 10 suppository Has specific active ingredient Diclofenac sodium true Inferred relationship Existential restriction modifier
Voltarol 100mg suppositories (Novartis Pharmaceuticals UK Ltd) 10 suppository Has dispensed dose form Suppository true Inferred relationship Existential restriction modifier
Voltarol 100mg suppositories (Novartis Pharmaceuticals UK Ltd) 10 suppository Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start